These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 657163
1. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. Pacciarini MA, Barbieri B, Colombo T, Broggini M, Garattini S, Donelli MG. Cancer Treat Rep; 1978 May; 62(5):791-800. PubMed ID: 657163 [Abstract] [Full Text] [Related]
2. Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors. Broggini M, Italia C, Colombo T, Marmonti L, Donelli MG. Cancer Treat Rep; 1984 May; 68(5):739-47. PubMed ID: 6586294 [Abstract] [Full Text] [Related]
3. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors. Sirotnak FM, Otter GM, Schmid FA. Cancer Res; 1993 Feb 01; 53(3):587-91. PubMed ID: 8425192 [Abstract] [Full Text] [Related]
4. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide. Ramonas LM, Erickson LC, Ringsdorf H, Zaharko DS. Cancer Res; 1980 Oct 01; 40(10):3704-8. PubMed ID: 7438053 [Abstract] [Full Text] [Related]
5. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model. Shiraga E, Barichello JM, Ishida T, Kiwada H. Int J Pharm; 2008 Apr 02; 353(1-2):65-73. PubMed ID: 18155369 [Abstract] [Full Text] [Related]
8. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice. Broggini M, Colombo T, D'Incalci M. Cancer Treat Rep; 1983 Jun 02; 67(6):555-9. PubMed ID: 6861161 [Abstract] [Full Text] [Related]
11. 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation. Cividalli A, Danesi DT, Altavista P, Bonanni M, Persiani D, Segre L, Cruciani G. Anticancer Res; 1995 Jun 02; 15(3):739-43. PubMed ID: 7645951 [Abstract] [Full Text] [Related]
13. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin. Israel M, Modest EJ, Frei E. Cancer Res; 1975 May 02; 35(5):1365-8. PubMed ID: 1054622 [Abstract] [Full Text] [Related]
14. Interaction between heparin and adriamycin in mice bearing the Lewis lung carcinoma. Colombo T, Delaini F, Ferrari R, Donati MB, Donelli MG, Poggi A. Biomedicine; 1981 Dec 02; 34(3):124-8. PubMed ID: 7337798 [Abstract] [Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1996 Aug 02; 383():1-370. PubMed ID: 12692653 [Abstract] [Full Text] [Related]